Teladoc Health (TDOC) Securities Investigation Notice - Levi & Korsinsky

Teladoc Health shares fell more than 28% after the Company reported Q2 2026 revenue of $606.9 million and cut its full-year 2026 revenue guidance. Levi & Korsinsky investigates. NEW YORK, Aug. 7, 2026 /PRNewswire/ -- Teladoc Health (NYSE: TDOC) shares dropped more than 28% after the...